Ghit Amr Saad Shehata Rizk

Ruolo:
Assegnista di ricerca
Settore scientifico disciplinare:
Malattie del sangue (MEDS-09/B)
Gruppo scientifico disciplinare:
MALATTIE DEL SANGUE, ONCOLOGIA E REUMATOLOGIA (06/MEDS-09)

Pubblicazioni

  • Henson, J., Ghit, A., Tziannou, A., James, E., Edwardson, C., Bishop, N., et al. (2025). Proteomics insights: exploring the inflammatory and metabolic signatures of ethnicity and change in physical activity in non-diabetic hyperglycaemia. EBIOMEDICINE, 121(November 2025) [10.1016/j.ebiom.2025.106006]. Dettaglio

  • Hikal, W., Kačániova, M., Hussein, D., Ghit, A., Smaoui, S., Aleem, M., et al. (2023). Dental unit waterlines and health risks of pathogenic microbial contamination: An update review. JOURNAL OF BIOLOGICAL STUDIES, 6(4), 282-298 [10.62400/jbs.v6i4.8729]. Dettaglio

  • Abdelazim, K., Ghit, A., Assal, D., Dorra, N., Noby, N., Khattab, S., et al. (2023). Production and therapeutic use of astaxanthin in the nanotechnology era. PHARMACOLOGICAL REPORTS, 75(4), 771-790 [10.1007/s43440-023-00488-y]. Dettaglio

  • Ahmed, A., Ghit, A., El Kazzaz, M. (2023). Pregnant and Breastfeeding Mothers Who Have Received the ChAdOx1 AstraZeneca COVID-19 Vaccine May Have Infants with an Increased Risk of Zinc Insufficiency and SCID Disease. ADVANCED PHARMACEUTICAL BULLETIN, 13(2), 216-217 [10.34172/apb.2023.024]. Dettaglio

  • Di Dalmazi, G., Coluzzi, S., Baldassarre, M., Ghit, A., Graziano, G., Rossi, M., et al. (2022). Effectiveness and Tolerability of Once-Weekly GLP-1 Receptor Agonists in Clinical Practice: A Focus on Switching Between Once-Weekly Molecules in Type 2 Diabetes. FRONTIERS IN ENDOCRINOLOGY, 13 [10.3389/fendo.2022.892702]. Dettaglio